CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-09 | Gheuens Sarah Chief Medical Officer | Option exercise · Stock options (right to buy) 10b5-1 | −11,914 | 32,086 | ||
| 2025-07-08 | Backstrom Jay T. Director | Grant or award · Stock options (right to buy) | +23,393 | 23,393 | ||
| 2025-07-08 | Backstrom Jay T. Director | Grant or award · Restricted stock units | +4,341 | 4,341 | ||
| 2025-07-01 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +8,374 | 65,362 | ||
| 2025-07-01 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −4,091 | $34.17 | $140K | 61,271 |
| 2025-07-01 | Gheuens Sarah Chief Medical Officer | Option exercise · Restricted stock units 10b5-1 | −8,374 | 8,375 | ||
| 2025-06-24 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +6,000 | 31,449 | ||
| 2025-06-24 | Burns James William Chief Legal Officer | Sale 10b5-1 | −2,799 | $33.54 | $94K | 28,650 |
| 2025-06-24 | Burns James William Chief Legal Officer | Option exercise · Performance share units 10b5-1 | −6,000 | 6,000 | ||
| 2025-06-24 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +6,000 | 59,897 | ||
| 2025-06-24 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −2,909 | $33.54 | $98K | 56,988 |
| 2025-06-24 | Gheuens Sarah Chief Medical Officer | Option exercise · Performance share units 10b5-1 | −6,000 | 6,000 | ||
| 2025-06-24 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +6,000 | 31,829 | ||
| 2025-06-24 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,780 | $33.54 | $60K | 30,049 |
| 2025-06-24 | Jones Cecilia Chief Financial Officer | Option exercise · Performance share units 10b5-1 | −6,000 | 6,000 | ||
| 2025-06-24 | Milanova Tsveta Chief Commercial Officer | Option exercise 10b5-1 | +6,000 | 28,892 | ||
| 2025-06-24 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −2,770 | $33.54 | $93K | 26,122 |
| 2025-06-24 | Milanova Tsveta Chief Commercial Officer | Option exercise · Performance share units 10b5-1 | −6,000 | 6,000 | ||
| 2025-06-24 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +25,527 | 117,872 | ||
| 2025-06-24 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −12,471 | $33.54 | $418K | 105,401 |
Page 12 of 48 · 941 trades